Lindt says GLP-1 users are eating more chocolate, not less

Lindt said chocolate sales are rising faster among U.S. users of GLP-1 weight-loss drugs than in the rest of the population, contradicting expectations that GLP-1 adoption would reduce confectionery demand. The company cited data showing this counterintuitive trend, suggesting demand for chocolate may be more resilient than feared and providing modestly positive implications for Lindt's revenue outlook.

Analysis

Lindt said chocolate sales are rising faster among U.S. users of GLP-1 weight-loss drugs than in the rest of the population, contradicting expectations that GLP-1 adoption would reduce confectionery demand. The company cited data showing this counterintuitive trend, suggesting demand for chocolate may be more resilient than feared and providing modestly positive implications for Lindt's revenue outlook.